Uncovering the DNA methylome in chronic lymphocytic leukemia

References

• Zenz T, Mertens D, Küppers R, Döhner H, Stilgenbauer S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 2010; 10:37 - 50; PMID: 19956173
   PubMed Web of Science ®Google Scholar
• Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16:168 - 74; http://dx.doi.org/10.1016/S0168-9525(99)01971-X; PMID: 10729832
   PubMed Web of Science ®Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6 - 21; http://dx.doi.org/10.1101/gad.947102; PMID: 11782440
   PubMed Web of Science ®Google Scholar
• Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295 - 304; http://dx.doi.org/10.1038/nrg2540; PMID: 19308066
   PubMed Web of Science ®Google Scholar
• Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002; 99:3740 - 5; http://dx.doi.org/10.1073/pnas.052410099; PMID: 11891299
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007; 16:Spec No 1 R50 - 9; http://dx.doi.org/10.1093/hmg/ddm018; PMID: 17613547
   PubMed Web of Science ®Google Scholar
• Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007; 6:1001 - 5; http://dx.doi.org/10.4161/cc.6.9.4209; PMID: 17457051
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415 - 28; PMID: 12042769
   PubMed Web of Science ®Google Scholar
• Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300:455; http://dx.doi.org/10.1126/science.1083557; PMID: 12702868
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Frigola J, Vendrell E, Risques RA, Fraga MF, Morales C, et al. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 2006; 66:8462 - 9468; http://dx.doi.org/10.1158/0008-5472.CAN-06-0293; PMID: 16951157
   PubMed Web of Science ®Google Scholar
• Lipsanen V, Leinonen P, Alhonen L, Jänne J. Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. Blood 1988; 72:2042 - 4; PMID: 2904292
   PubMed Web of Science ®Google Scholar
• Wahlfors J, Hiltunen H, Heinonen K, Hämäläinen E, Alhonen L, Jänne J. Genomic hypomethylation in human chronic lymphocytic leukemia. Blood 1992; 80:2074 - 80; PMID: 1382719
   PubMed Web of Science ®Google Scholar
• Fabris S, Bollati V, Agnelli L, Morabito F, Motta V, Cutrona G, et al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 2011; 6:188 - 94; http://dx.doi.org/10.4161/epi.6.2.13528; PMID: 20930513
   PubMed Web of Science ®Google Scholar
• Kulis M, Heath S, Bibikova M, Queirós AC, Navarro A, Clot G, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 2012; 44:1236 - 42; http://dx.doi.org/10.1038/ng.2443; PMID: 23064414
   PubMed Web of Science ®Google Scholar
• Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82:1820 - 8; PMID: 8104532
   PubMed Web of Science ®Google Scholar
• Kantharidis P, El-Osta A, deSilva M, Wall DM, Hu XF, Slater A, et al. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clin Cancer Res 1997; 3:2025 - 32; PMID: 9815593
   PubMed Web of Science ®Google Scholar
• Yuille MR, Condie A, Stone EM, Wilsher J, Bradshaw PS, Brooks L, et al. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Genes Chromosomes Cancer 2001; 30:336 - 41; http://dx.doi.org/10.1002/gcc.1099; PMID: 11241786
   PubMed Web of Science ®Google Scholar
• Melki JR, Vincent PC, Brown RD, Clark SJ. Hypermethylation of E-cadherin in leukemia. Blood 2000; 95:3208 - 13; PMID: 10807790
   PubMed Web of Science ®Google Scholar
• Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14:6107 - 15; PMID: 8557030
   PubMed Web of Science ®Google Scholar
• Seeliger B, Wilop S, Osieka R, Galm O, Jost E. CpG island methylation patterns in chronic lymphocytic leukemia. Leuk Lymphoma 2009; 50:419 - 26; http://dx.doi.org/10.1080/10428190902756594; PMID: 19347729
   PubMed Web of Science ®Google Scholar
• Bechter OE, Eisterer W, Dlaska M, Kühr T, Thaler J. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Exp Hematol 2002; 30:26 - 33; http://dx.doi.org/10.1016/S0301-472X(01)00760-3; PMID: 11823034
   PubMed Web of Science ®Google Scholar
• Raval A, Lucas DM, Matkovic JJ, Bennett KL, Liyanarachchi S, Young DC, et al. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J Clin Oncol 2005; 23:3877 - 85; http://dx.doi.org/10.1200/JCO.2005.02.196; PMID: 15809452
   PubMed Web of Science ®Google Scholar
• Corcoran M, Parker A, Orchard J, Davis Z, Wirtz M, Schmitz OJ, et al. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 2005; 90:1078 - 88; PMID: 16079107
   PubMed Web of Science ®Google Scholar
• Chantepie SP, Vaur D, Grunau C, Salaün V, Briand M, Parienti JJ, et al. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia. Leuk Res 2010; 34:800 - 8; http://dx.doi.org/10.1016/j.leukres.2009.10.018; PMID: 19944462
   PubMed Web of Science ®Google Scholar
• Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu LB, Zucknick M, et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J Clin Oncol 2012; 30:2483 - 91; http://dx.doi.org/10.1200/JCO.2011.39.3090; PMID: 22564988
   PubMed Web of Science ®Google Scholar
• Strathdee G, Sim A, Parker A, Oscier D, Brown R. Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 2006; 20:1326 - 9; http://dx.doi.org/10.1038/sj.leu.2404254; PMID: 16688227
   PubMed Web of Science ®Google Scholar
• Cillo C, Cantile M, Faiella A, Boncinelli E. Homeobox genes in normal and malignant cells. J Cell Physiol 2001; 188:161 - 9; http://dx.doi.org/10.1002/jcp.1115; PMID: 11424082
   PubMed Web of Science ®Google Scholar
• Strathdee G, Holyoake TL, Sim A, Parker A, Oscier DG, Melo JV, et al. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 2007; 13:5048 - 55; http://dx.doi.org/10.1158/1078-0432.CCR-07-0919; PMID: 17785556
   PubMed Web of Science ®Google Scholar
• Irving L, Mainou-Fowler T, Parker A, Ibbotson RE, Oscier DG, Strathdee G. Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia. Epigenetics 2011; 6:300 - 6; http://dx.doi.org/10.4161/epi.6.3.14038; PMID: 21051931
   PubMed Web of Science ®Google Scholar
• Fülöp Z, Csernus B, Tímár B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter’s transformation of chronic lymphocytic leukemia. Leukemia 2003; 17:411 - 5; http://dx.doi.org/10.1038/sj.leu.2402792; PMID: 12592341
   PubMed Web of Science ®Google Scholar
• Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007; 129:879 - 90; http://dx.doi.org/10.1016/j.cell.2007.03.043; PMID: 17540169
   PubMed Web of Science ®Google Scholar
• Hanoun M, Eisele L, Suzuki M, Greally JM, Hüttmann A, Aydin S, et al. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One 2012; 7:e34347; http://dx.doi.org/10.1371/journal.pone.0034347; PMID: 22470559
   PubMed Web of Science ®Google Scholar
• Dunwell TL, Dickinson RE, Stankovic T, Dallol A, Weston V, Austen B, et al. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia. Epigenetics 2009; 4:265 - 9; PMID: 19550140
   PubMed Web of Science ®Google Scholar
• Liu TH, Raval A, Chen SS, Matkovic JJ, Byrd JC, Plass C. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res 2006; 66:653 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-05-3712; PMID: 16423993
   PubMed Web of Science ®Google Scholar
• Chim CS, Pang R, Liang R. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia. J Clin Pathol 2008; 61:1214 - 9; http://dx.doi.org/10.1136/jcp.2008.060152; PMID: 18765431
   PubMed Web of Science ®Google Scholar
• Moskalev EA, Luckert K, Vorobjev IA, Mastitsky SE, Gladkikh AA, Stephan A, et al. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer 2012; 12:213; http://dx.doi.org/10.1186/1471-2407-12-213; PMID: 22672427
   PubMed Web of Science ®Google Scholar
• Shinawi T, Hill V, Dagklis A, Baliakas P, Stamatopoulos K, Agathanggelou A, et al. KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia. Epigenetics 2012; 7:211 - 5; http://dx.doi.org/10.4161/epi.7.3.19222; PMID: 22430796
   PubMed Web of Science ®Google Scholar
• Lyko F, Stach D, Brenner A, Stilgenbauer S, Döhner H, Wirtz M, et al. Quantitative analysis of DNA methylation in chronic lymphocytic leukemia patients. Electrophoresis 2004; 25:1530 - 5; http://dx.doi.org/10.1002/elps.200305830; PMID: 15188237
   PubMed Web of Science ®Google Scholar
• Yu MK, Bergonia H, Szabo A, Phillips JD. Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index. Leuk Res 2007; 31:773 - 7; http://dx.doi.org/10.1016/j.leukres.2006.07.007; PMID: 16970987
   PubMed Web of Science ®Google Scholar
• Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004; 64:2424 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-03-2870; PMID: 15059895
   PubMed Web of Science ®Google Scholar
• Rahmatpanah FB, Carstens S, Hooshmand SI, Welsh EC, Sjahputera O, Taylor KH, et al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 2009; 1:39 - 61; http://dx.doi.org/10.2217/epi.09.10; PMID: 20495622
   PubMed Web of Science ®Google Scholar
• Cahill N, Bergh AC, Kanduri M, Goransson-Kultima H, Mansouri L, Isaksson A, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013; 27:150 - 8; PMID: 22922567
   PubMed Web of Science ®Google Scholar
• Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, Estrov Z, et al. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 2010; 5:499 - 508; http://dx.doi.org/10.4161/epi.5.6.12179; PMID: 20484983
   PubMedGoogle Scholar
• Kanduri M, Cahill N, Göransson H, Enström C, Ryan F, Isaksson A, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 2010; 115:296 - 305; http://dx.doi.org/10.1182/blood-2009-07-232868; PMID: 19897574
   PubMed Web of Science ®Google Scholar
• Kanduri M, Marincevic M, Halldórsdóttir AM, Mansouri L, Junevik K, Ntoufa S, et al. Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles. Epigenetics 2012; 7:1435 - 42; http://dx.doi.org/10.4161/epi.22901; PMID: 23154584
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178 - 86; http://dx.doi.org/10.1038/ng.298; PMID: 19151715
   PubMed Web of Science ®Google Scholar
• Halldórsdóttir AM, Sander B, Göransson H, Isaksson A, Kimby E, Mansouri M, et al. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival. Genes Chromosomes Cancer 2011; 50:113 - 21; http://dx.doi.org/10.1002/gcc.20836; PMID: 21117067
   PubMed Web of Science ®Google Scholar
• Pei LR, Choi JH, Liu JM, Lee EJ, McCarthy B, Wilson JM, et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics 2012; 7:567 - 78; http://dx.doi.org/10.4161/epi.20237; PMID: 22534504
   PubMed Web of Science ®Google Scholar
• Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG, et al. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis 2010; 31:745 - 50; http://dx.doi.org/10.1093/carcin/bgq033; PMID: 20118199
   PubMed Web of Science ®Google Scholar
• Wong KY, So CC, Loong F, Chung LP, Lam WW, Liang R, et al. Epigenetic inactivation of the miR-124-1 in haematological malignancies. PLoS One 2011; 6:e19027; http://dx.doi.org/10.1371/journal.pone.0019027; PMID: 21544199
   PubMedGoogle Scholar
• Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L, et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res 2012; 72:3775 - 85; http://dx.doi.org/10.1158/0008-5472.CAN-12-0803; PMID: 22710432
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99:15524 - 9; http://dx.doi.org/10.1073/pnas.242606799; PMID: 12434020
   PubMed Web of Science ®Google Scholar
• Calin GA, Pekarsky Y, Croce CM. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007; 20:425 - 37; http://dx.doi.org/10.1016/j.beha.2007.02.003; PMID: 17707831
   PubMed Web of Science ®Google Scholar
• Nicoloso MS, Kipps TJ, Croce CM, Calin GA. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol 2007; 139:709 - 16; http://dx.doi.org/10.1111/j.1365-2141.2007.06868.x; PMID: 18021085
   PubMed Web of Science ®Google Scholar
• Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, et al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009; 114:3872 - 9; http://dx.doi.org/10.1182/blood-2009-06-229211; PMID: 19717645
   PubMed Web of Science ®Google Scholar
• Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17:28 - 40; http://dx.doi.org/10.1016/j.ccr.2009.11.019; PMID: 20060366
   PubMed Web of Science ®Google Scholar
• Zenz T, Häbe S, Denzel T, Mohr J, Winkler D, Bühler A, et al. Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood 2009; 114:2589 - 97; http://dx.doi.org/10.1182/blood-2009-05-224071; PMID: 19643983
   PubMed Web of Science ®Google Scholar
• Chim CS, Wong KY, Leung CY, Chung LP, Hui PK, Chan SY, et al. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J Cell Mol Med 2011; 15:2760 - 7; http://dx.doi.org/10.1111/j.1582-4934.2011.01274.x; PMID: 21323860
   PubMed Web of Science ®Google Scholar
• Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 2009; 114:3255 - 64; http://dx.doi.org/10.1182/blood-2009-06-229898; PMID: 19692702
   PubMed Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31:27 - 36; http://dx.doi.org/10.1093/carcin/bgp220; PMID: 19752007
   PubMed Web of Science ®Google Scholar
• Chen SS, Raval A, Johnson AJ, Hertlein E, Liu TH, Jin VX, et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2009; 106:13433 - 8; http://dx.doi.org/10.1073/pnas.0906455106; PMID: 19666576
   PubMed Web of Science ®Google Scholar
• Chen SS, Sherman MH, Hertlein E, Johnson AJ, Teitell MA, Byrd JC, et al. Epigenetic alterations in a murine model for chronic lymphocytic leukemia. Cell Cycle 2009; 8:3663 - 7; http://dx.doi.org/10.4161/cc.8.22.9957; PMID: 19901553
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, Winkler D, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007; 92:1242 - 5; http://dx.doi.org/10.3324/haematol.10720; PMID: 17666364
   PubMed Web of Science ®Google Scholar
• Gunnarsson R, Mansouri L, Isaksson A, Göransson H, Cahill N, Jansson M, et al. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica 2011; 96:1161 - 9; http://dx.doi.org/10.3324/haematol.2010.039768; PMID: 21546498
   PubMed Web of Science ®Google Scholar
• Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 2008; 112:4202 - 12; http://dx.doi.org/10.1182/blood-2008-03-147645; PMID: 18713946
   PubMed Web of Science ®Google Scholar
• Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, et al. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 2010; 12:1108 - 14; http://dx.doi.org/10.1038/ncb2116; PMID: 20935635
   PubMed Web of Science ®Google Scholar
• Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV, et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 2010; 42:722 - 6; http://dx.doi.org/10.1038/ng.621; PMID: 20601953
   PubMed Web of Science ®Google Scholar
• Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011; 43:309 - 15; http://dx.doi.org/10.1038/ng.788; PMID: 21399634
   PubMed Web of Science ®Google Scholar
• Kn H, Bassal S, Tikellis C, El-Osta A. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL). Cancer Biol Ther 2004; 3:989 - 94; http://dx.doi.org/10.4161/cbt.3.10.1137; PMID: 15467427
   PubMed Web of Science ®Google Scholar
• Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007; 104:15805 - 10; http://dx.doi.org/10.1073/pnas.0707628104; PMID: 17890317
   PubMed Web of Science ®Google Scholar
• Santanam U, Zanesi N, Efanov A, Costinean S, Palamarchuk A, Hagan JP, et al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci U S A 2010; 107:12210 - 5; http://dx.doi.org/10.1073/pnas.1007186107; PMID: 20566844
   PubMed Web of Science ®Google Scholar
• Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, et al. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 2012; 119:1162 - 72; http://dx.doi.org/10.1182/blood-2011-05-351510; PMID: 22096249
   PubMed Web of Science ®Google Scholar
• Palamarchuk A, Yan PS, Zanesi N, Wang L, Rodrigues B, Murphy M, et al. Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). Proc Natl Acad Sci U S A 2012; 109:2555 - 60; http://dx.doi.org/10.1073/pnas.1200003109; PMID: 22308499
   PubMed Web of Science ®Google Scholar
• Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007; 448:714 - 7; http://dx.doi.org/10.1038/nature05987; PMID: 17687327
   PubMed Web of Science ®Google Scholar
• Amin S, Walsh M, Wilson C, Parker AE, Oscier D, Willmore E, et al. Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL. J Cell Mol Med 2012; 16:2074 - 84; http://dx.doi.org/10.1111/j.1582-4934.2011.01503.x; PMID: 22151263
   PubMed Web of Science ®Google Scholar
• Billot K, Soeur J, Chereau F, Arrouss I, Merle-Béral H, Huang ME, et al. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications. Blood 2011; 117:1917 - 27; http://dx.doi.org/10.1182/blood-2010-09-307140; PMID: 21139082
   PubMed Web of Science ®Google Scholar
• Chen SS, Claus R, Lucas DM, Yu L, Qian J, Ruppert AS, et al. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood 2011; 117:862 - 71; http://dx.doi.org/10.1182/blood-2010-05-284638; PMID: 21098398
   PubMed Web of Science ®Google Scholar
• Motiwala T, Majumder S, Kutay H, Smith DS, Neuberg DS, Lucas DM, et al. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. Clin Cancer Res 2007; 13:3174 - 81; http://dx.doi.org/10.1158/1078-0432.CCR-06-1720; PMID: 17545520
   PubMed Web of Science ®Google Scholar
• Motiwala T, Zanesi N, Datta J, Roy S, Kutay H, Checovich AM, et al. AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia. Blood 2011; 118:6132 - 40; http://dx.doi.org/10.1182/blood-2011-01-323147; PMID: 22001392
   PubMed Web of Science ®Google Scholar
• Moreno P, Abreu C, Borge M, Morande P, Pegazzano M, Palacios F, et al. Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment. Leukemia 2012; In Press http://dx.doi.org/10.1038/leu.2012.212; PMID: 22828442
   PubMed Web of Science ®Google Scholar
• Kaderi MA, Kanduri M, Buhl AM, Sevov M, Cahill N, Gunnarsson R, et al. LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 2011; 96:1153 - 60; http://dx.doi.org/10.3324/haematol.2010.039396; PMID: 21508119
   PubMed Web of Science ®Google Scholar
• Seifert M, Sellmann L, Bloehdorn J, Wein F, Stilgenbauer S, Dürig J, et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 2012; 209:2183 - 98; http://dx.doi.org/10.1084/jem.20120833; PMID: 23091163
   PubMed Web of Science ®Google Scholar
• Buhl AM, Jurlander J, Geisler CH, Pedersen LB, Andersen MK, Josefsson P, et al. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia. Eur J Haematol 2006; 76:455 - 64; http://dx.doi.org/10.1111/j.0902-4441.2005.t01-1-EJH2530.x; PMID: 16529606
   PubMed Web of Science ®Google Scholar
• Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208:1389 - 401; http://dx.doi.org/10.1084/jem.20110921; PMID: 21670202
   PubMed Web of Science ®Google Scholar
• Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, et al. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 2002; 21:3172 - 80; http://dx.doi.org/10.1038/sj.onc.1205462; PMID: 12082632
   PubMed Web of Science ®Google Scholar
• Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260:1317 - 20; http://dx.doi.org/10.1126/science.8493574; PMID: 8493574
   PubMed Web of Science ®Google Scholar
• Matsuda S, Yokozaki S, Yoshida H, Kitagishi Y, Shirafuji N, Okumura N. Insulin receptor substrate protein 53 (IRSp53) as a binding partner of antimetastasis molecule NESH, a member of Abelson interactor protein family. Ann Oncol 2008; 19:1356 - 7; http://dx.doi.org/10.1093/annonc/mdn293; PMID: 18480067
   PubMed Web of Science ®Google Scholar
• Vargova K, Curik N, Burda P, Basova P, Kulvait V, Pospisil V, et al. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 2011; 117:3816 - 25; http://dx.doi.org/10.1182/blood-2010-05-285064; PMID: 21296997
   PubMed Web of Science ®Google Scholar
• Gutierrez A Jr., Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, Huddleston PM 3rd, et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 2010; 116:2975 - 83; http://dx.doi.org/10.1182/blood-2010-02-269878; PMID: 20595513
   PubMed Web of Science ®Google Scholar
• Moreno DA, Scrideli CA, Cortez MA, de Paula Queiroz R, Valera ET, da Silva Silveira V, et al. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. Br J Haematol 2010; 150:665 - 73; http://dx.doi.org/10.1111/j.1365-2141.2010.08301.x; PMID: 20636436
   PubMed Web of Science ®Google Scholar